TUBA1B and cancer: Considering that TMB, MSI, and NEO are all considered potential predictive biomarkers for immunotherapy response30, we explored the relationship between TUBA1B expression levels and these biomarkers and identified significant correlations between TUBA1B expression and TMB in 14 cancer types.